Characterization of a novel AEL allele harboring a c.28 + 5G>A mutation on the ABO*A2.01 background: a study utilizing PacBio third-generation sequencing and functional assays
2024

Study of a New AEL Allele in Blood Group Genetics

Sample size: 1 publication Evidence: high

Author Information

Author(s): Shao Lin-Nan, Song Wen-Qian, Zhou Lu, Pan Ling-Zi, Duan Ying, Xiao Nan, Zhou Shi-Hang, Liang Xiao-Hua

Primary Institution: Blood Group Reference Laboratory, Dalian Blood Center, Dalian, China

Hypothesis

The study aimed to characterize the molecular mechanism underlying a novel AEL allele associated with an intron splice site mutation.

Conclusion

A novel AEL allele was identified in a Chinese male blood donor, characterized by the c.28 + 5G>A variant, which alters normal splicing and leads to a truncated glycosyltransferase.

Supporting Evidence

  • The proband exhibited an atypical agglutination pattern.
  • PacBio sequencing revealed a novel ABO*A2.01-like allele with a c.28 + 5G>A mutation.
  • Minigene analysis indicated that the mutation disrupted normal splicing.

Takeaway

Scientists found a new type of blood group that changes how blood cells behave, which can affect blood transfusions.

Methodology

PacBio sequencing and minigene splicing assays were used to analyze the ABO gene and its mutations.

Participant Demographics

A 53-year-old healthy male blood donor.

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1396426

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication